Arkolith/Insider Trading/OVID/Form 4

Levin Jeremy M

CEO, DirectorOvid Therapeutics Inc. (OVID) · full profile →Form 4 · filed Mar 20, 2024
Net Buying
Open-Market Buys
$50K
Open-Market Sells
$0
Net Open-Market Flow
$50K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 18, 2024Buy(P)18K$2.76$50K3.6M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-24-005001) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML